Tiziana Life Sciences announced the appointment of Professor Roberto Pellicciari to the company's Scientific Advisory Board and as a consultant to the company. Professor Pellicciari was the co-founder and remains Head of Medicinal Chemistry at Intercept Pharmaceuticals Inc. Professor Pellicciari is presently Professor of Medicinal Chemistry at the University of Perugia in Italy and has held a number of prestigious scientific posts.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.741 USD | +0.04% | -0.40% | +32.32% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+32.32% | 74.3M | |
+65.76% | 62.86B | |
-0.89% | 41.38B | |
+45.72% | 40.38B | |
-8.93% | 27.64B | |
+12.94% | 26.46B | |
-22.51% | 18.9B | |
+3.69% | 12.67B | |
+25.13% | 12.27B | |
+27.97% | 12.07B |
- Stock Market
- Equities
- TLSA Stock
- News Tiziana Life Sciences Ltd
- Tiziana Life Sciences Appoints Roberto Pellicciari to the Scientific Advisory Board